InsiderClue
Insiders · Profile

Lerner Lorena Raquel

Chief Scientific Officer at Keros Therapeutics. Filing since 18 Feb 2026. CIK 0002081359

Company
Date
Role
Action
Shares
Amount
Of holding
KROS Keros Therapeutics, Inc.
18 Aug 2026
Chief Scientific Officer
Sold at will
3,568
$36.71K
11.5%
KROS Keros Therapeutics, Inc.
18 Feb 2026
Chief Science Officer
Sold at will
3,873
$63.32K
11.1%
2 decisions on file.